{"id":"https://openalex.org/W4367396950","doi":"https://doi.org/10.1016/j.urolonc.2023.04.005","title":"Sequential intravesical gemcitabine-docetaxel vs. bacillus Calmette-Guerin (BCG) in the treatment of non-muscle invasive bladder cancer: A preliminary cost-effectiveness analysis","display_name":"Sequential intravesical gemcitabine-docetaxel vs. bacillus Calmette-Guerin (BCG) in the treatment of non-muscle invasive bladder cancer: A preliminary cost-effectiveness analysis","publication_year":2023,"publication_date":"2023-04-29","ids":{"openalex":"https://openalex.org/W4367396950","doi":"https://doi.org/10.1016/j.urolonc.2023.04.005","pmid":"https://pubmed.ncbi.nlm.nih.gov/37127478"},"language":"en","primary_location":{"id":"doi:10.1016/j.urolonc.2023.04.005","doi":"https://doi.org/10.1016/j.urolonc.2023.04.005","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.urolonc.2023.04.005","pdf_url":null,"source":{"id":"https://openalex.org/S4802544","display_name":"Urologic Oncology Seminars and Original Investigations","issn_l":"1078-1439","issn":["1078-1439","1873-2496"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Urologic Oncology: Seminars and Original Investigations","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008460713","display_name":"Laura Bukavina","orcid":"https://orcid.org/0000-0001-7129-6230","observed_orcids":["https://orcid.org/0000-0001-7129-6230"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I4210122924","display_name":"Temple University Health System","ror":"https://ror.org/02fhvxj45","country_code":"US","type":"education","lineage":["https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura Bukavina","raw_affiliation_strings":["Division of Urologic Oncology, Department of Surgery, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Urologic Oncology, Department of Surgery, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA","institution_ids":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012205570","display_name":"Spencer Bell","orcid":"https://orcid.org/0000-0002-1766-3703","observed_orcids":["https://orcid.org/0000-0002-1766-3703","https://orcid.org/0009-0003-3317-6846"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I4210122924","display_name":"Temple University Health System","ror":"https://ror.org/02fhvxj45","country_code":"US","type":"education","lineage":["https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Spencer Bell","raw_affiliation_strings":["Division of Urologic Oncology, Department of Surgery, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Urologic Oncology, Department of Surgery, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA","institution_ids":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083626538","display_name":"Vignesh T. Packiam","orcid":"https://orcid.org/0000-0001-8397-7797","observed_orcids":["https://orcid.org/0000-0001-8397-7797"]},"institutions":[{"id":"https://openalex.org/I126307644","display_name":"University of Iowa","ror":"https://ror.org/036jqmy94","country_code":"US","type":"education","lineage":["https://openalex.org/I126307644"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vignesh T. Packiam","raw_affiliation_strings":["Department of Urology, University of Iowa, Iowa City, IA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, University of Iowa, Iowa City, IA","institution_ids":["https://openalex.org/I126307644"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080057051","display_name":"Marc C. Smaldone","orcid":"https://orcid.org/0000-0003-4160-0005","observed_orcids":["https://orcid.org/0000-0003-4160-0005"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I4210122924","display_name":"Temple University Health System","ror":"https://ror.org/02fhvxj45","country_code":"US","type":"education","lineage":["https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marc Smaldone","raw_affiliation_strings":["Division of Urologic Oncology, Department of Surgery, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Urologic Oncology, Department of Surgery, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA","institution_ids":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011122559","display_name":"Philip H. Abbosh","orcid":"https://orcid.org/0000-0003-3611-9532","observed_orcids":["https://orcid.org/0000-0003-3611-9532"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I4210122924","display_name":"Temple University Health System","ror":"https://ror.org/02fhvxj45","country_code":"US","type":"education","lineage":["https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Philip Abbosh","raw_affiliation_strings":["Division of Urologic Oncology, Department of Surgery, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Urologic Oncology, Department of Surgery, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA","institution_ids":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043554307","display_name":"Robert G. Uzzo","orcid":"https://orcid.org/0000-0003-2398-6530","observed_orcids":["https://orcid.org/0000-0003-2398-6530"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I4210122924","display_name":"Temple University Health System","ror":"https://ror.org/02fhvxj45","country_code":"US","type":"education","lineage":["https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Uzzo","raw_affiliation_strings":["Division of Urologic Oncology, Department of Surgery, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Urologic Oncology, Department of Surgery, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA","institution_ids":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091629756","display_name":"Alexander Kutikov","orcid":"https://orcid.org/0000-0003-1525-6247","observed_orcids":["https://orcid.org/0000-0003-1525-6247"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I4210122924","display_name":"Temple University Health System","ror":"https://ror.org/02fhvxj45","country_code":"US","type":"education","lineage":["https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexander Kutikov","raw_affiliation_strings":["Division of Urologic Oncology, Department of Surgery, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Urologic Oncology, Department of Surgery, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA","institution_ids":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040964782","display_name":"Andres F. Correa","orcid":"https://orcid.org/0000-0001-8506-7324","observed_orcids":["https://orcid.org/0000-0001-8506-7324"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I4210122924","display_name":"Temple University Health System","ror":"https://ror.org/02fhvxj45","country_code":"US","type":"education","lineage":["https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andres F. Correa","raw_affiliation_strings":["Division of Urologic Oncology, Department of Surgery, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Urologic Oncology, Department of Surgery, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA","institution_ids":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045696014","display_name":"Diana Magee","orcid":"https://orcid.org/0000-0002-3948-2057","observed_orcids":["https://orcid.org/0000-0002-3948-2057"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I4210122924","display_name":"Temple University Health System","ror":"https://ror.org/02fhvxj45","country_code":"US","type":"education","lineage":["https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Diana E. Magee","raw_affiliation_strings":["Division of Urologic Oncology, Department of Surgery, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA. Electronic address: diana.magee@fccc.edu","Division of Urologic Oncology, Department of Surgery, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA"],"raw_orcid":"https://orcid.org/0000-0002-3948-2057","affiliations":[{"raw_affiliation_string":"Division of Urologic Oncology, Department of Surgery, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA. Electronic address: diana.magee@fccc.edu","institution_ids":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"raw_affiliation_string":"Division of Urologic Oncology, Department of Surgery, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA","institution_ids":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5045696014"],"corresponding_institution_ids":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"],"apc_list":{"value":3340,"currency":"USD","value_usd":3340},"apc_paid":null,"fwci":4.2677,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.95092681,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"41","issue":"9","first_page":"391.e1","last_page":"391.e4"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.019300000742077827,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-muscle-invasive-bladder-cancer","display_name":"non-muscle-invasive bladder cancer","score":0.9940000176429749},{"id":"https://openalex.org/keywords/intravesical-therapy","display_name":"intravesical therapy","score":0.8410000205039978},{"id":"https://openalex.org/keywords/gemcitabine-docetaxel","display_name":"gemcitabine/docetaxel","score":0.9810000061988831},{"id":"https://openalex.org/keywords/bcg-vaccine","display_name":"BCG vaccine","score":0.9700000286102295},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9169999957084656},{"id":"https://openalex.org/keywords/markov-model","display_name":"Markov model","score":0.746999979019165},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.9020000100135803},{"id":"https://openalex.org/keywords/medicare-spending","display_name":"Medicare spending","score":0.5600000023841858},{"id":"https://openalex.org/keywords/high-risk-bladder-cancer","display_name":"high-risk bladder cancer","score":0.6439999938011169},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.45500001311302185}],"concepts":[{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.9593860507011414},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.9247603416442871},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.842150092124939},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.6486874222755432},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.638984203338623},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.5064271688461304},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4705897867679596},{"id":"https://openalex.org/C515549039","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost-effectiveness analysis","level":3,"score":0.4603137671947479},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.31166744232177734},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000093284","descriptor_name":"Non-Muscle Invasive Bladder Neoplasms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000093542","descriptor_name":"Gemcitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000094703","descriptor_name":"Cost-Effectiveness Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000276","descriptor_name":"Adjuvants, Immunologic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000283","descriptor_name":"Administration, Intravesical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001500","descriptor_name":"BCG Vaccine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D006278","descriptor_name":"Medicare","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009361","descriptor_name":"Neoplasm Invasiveness","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.urolonc.2023.04.005","doi":"https://doi.org/10.1016/j.urolonc.2023.04.005","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.urolonc.2023.04.005","pdf_url":null,"source":{"id":"https://openalex.org/S4802544","display_name":"Urologic Oncology Seminars and Original Investigations","issn_l":"1078-1439","issn":["1078-1439","1873-2496"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Urologic Oncology: Seminars and Original Investigations","raw_type":"journal-article"},{"id":"pmid:37127478","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37127478","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Urologic oncology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000285491","display_name":"Comprehensive Cancer Center Program at Fox Chase","funder_award_id":"P30CA006927","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":8,"referenced_works":["https://openalex.org/W2134589781","https://openalex.org/W2140421779","https://openalex.org/W2144125109","https://openalex.org/W3026369794","https://openalex.org/W3034386282","https://openalex.org/W3198719997","https://openalex.org/W4280555297","https://openalex.org/W4288034088"],"related_works":["https://openalex.org/W4360607379","https://openalex.org/W1591494255","https://openalex.org/W4391303310","https://openalex.org/W7117156805","https://openalex.org/W4322617978","https://openalex.org/W4311332983","https://openalex.org/W6920790642","https://openalex.org/W4392881980","https://openalex.org/W4402682608","https://openalex.org/W2921542261"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-04-30T00:00:00"}